Phase II Clinical Trial to Evaluate the Efficacy and Safety of NV01-A02 in Children With Autism Spectrum Disorder

Clinical trial NCT06951854 · RECRUITING

Trial details

NCT number: NCT06951854
Sponsor: Neuroventi Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Autism Spectrum Disorder (ASD

Start date: 2025-04-01
Primary completion: 2025-09-01
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.